Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

Frontiers Health Steering Committee spotlight: Roberto Ascione

Vir awarded $1 billion multi-year BARDA influenza contract

GSK’s Jemperli/TIM-3 immuno-oncology combo moves to ph3

Digital health financing drops again, but don’t worry yet

Sanofi wagers $400m on miRecule muscular dystrophy therapy

Angelman Syndrome

Photo-D.-Loew

News/ News/ R&D

Ipsen forges $1bn alliance with Exicure on neurodegenerative diseases

Phil Taylor Angelman Syndrome, Exicure, Huntington's disease, Ipsen, neurodegenerative disease, partnering, rare disease 0 Comment

Ipsen’s new chief executive David Loew pledged to ramp up spending on the company’s pipeline when he took

X

Ipsen forges $1bn alliance with Exicure on neurodegenerative diseases

https://pharmaphorum.com/news/ipsen-forges-1bn-alliance-with-exicure-on-neurodegenerative-diseases/

Tim Guilliams (R) and David Brown (L)

Digital/ News/ News

Healx uses AI to find drugs for Angelman Syndrome

Richard Staines AI, Angelman Syndrome, digital, Healx, Rare diseases 0 Comment

The UK-based AI technology company Healx has begun a partnership with the Foundation for Angelman Syndrome Therapeutics (FAST),

X

Healx uses AI to find drugs for Angelman Syndrome

https://pharmaphorum.com/news/healx-uses-ai-to-find-drugs-for-angelman-syndrome/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Amylyx ALS drug draws criticism over $158,000 price tag
Roche gets FDA approval for HER2 breast cancer diagnostic
Translarna not approved by NICE for DMD on NHS
AstraZeneca pays record 660% premium for gene editing company LogicBio
Novo Nordisk achieve headline results with icodec insulin

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com